BBR Partners »

Nurix Therapeutics shares owned by BBR Partners

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by BBR Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $309k 21k 14.70
2023-09-30 $165k 21k 7.86
2023-03-31 $186k 21k 8.88

More positions owned by BBR Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
United Parcel Service CL B (UPS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Kkr & Co Cl A (KKR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard World Fds Inf Tech Etf (VGT)
Ishares Tr Russell 3000 Etf (IWV)
Alphabet Cap Stk Cl A (GOOGL)
Philip Morris International (PM)
Abbvie (ABBV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BBR Partners

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
ARK Investment Management
Vanguard Group
Morgan Stanley
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Bain Capital Life Sciences Investors
Soleus Capital Management
Geode Capital Management
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics